BRD4: New hope in the battle against glioblastoma
Author:
Funder
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Pharmacology
Reference173 articles.
1. The cellular origin for malignant glioma and prospects for clinical advancements.;Zong;Expert Rev. Mol. Diagn.,2012
2. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.;Louis;Neuro Oncol.,2021
3. Epidemiology and etiology of gliomas.;Ohgaki;Acta Neuropathol.,2005
4. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial;Stupp;Lancet Oncol.,2009
5. Metabolic Rewiring in Glioblastoma Cancer: EGFR, IDH and Beyond;El Khayari;Front Oncol.,2022
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. BRD4-specific PROTAC inhibits basal-like breast cancer partially through downregulating KLF5 expression;Oncogene;2024-08-20
2. Epigenetic clocks and gliomas: unveiling the molecular interactions between aging and tumor development;Frontiers in Molecular Biosciences;2024-07-26
3. A Review of the Bromodomain and Extraterminal Domain Epigenetic Reader Proteins: Function on Virus Infection and Cancer;Viruses;2024-07-08
4. Effects of BRD4 inhibitor JQ1 on the expression profile of super-enhancer related lncRNAs and mRNAs in cervical cancer HeLa cells;PeerJ;2024-02-23
5. Molecular subgroup establishment and signature creation of lncRNAs associated with acetylation in lung adenocarcinoma;Aging;2024-01-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3